Presented by the FDLI, the 21st annual Advertising and Promotion Conference will highlight advertising and promotion issues concerning prescription drugs, medical devices, biological products and animal drugs. The event will focus on updates from the four FDA medical products centers and will discuss practical issues facing the regulated industry such as DTC Advertising and the Draft Guidance on Presenting Risk Information, the use of social marketing/electronic media, and an OIG/DOJ settlements update.
Glenn Byrd will be giving an oral presentation on "Medical Guidelines vs. Promotion." MedImmune is a sponsor.
Added by MedImmune on September 26, 2011